
Number of publications published per year by Kong, Bo. (Source : PubMed)

Distribution of publications types for Kong, Bo. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Frequent hypermethylation and loss of heterozygosity of the testis derived transcript gene in ovarian cancer.
Cancer Sci.
2010
Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine.
Hepatology
2009

Expression of steroidogenic factor 1 (SF-1) and steroidogenic acute regulatory protein (StAR) in endometriosis is associated with endometriosis severity.
J. Int. Med. Res.
2009;37;5
CLIC4 mediates TGF-beta1-induced fibroblast-to-myofibroblast transdifferentiation in ovarian cancer.
Oncol. Rep.
2009;22;3
Molecular identification of "latent precancers" for endometrial serous carcinoma in benign-appearing endometrium.
Am. J. Pathol.
2009;174;6
Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway.
Cancer Lett.
2009;277;1


Decreased expression of neurotrophic tyrosine receptor kinase 3 is associated with the outflow tract defect of human tetralogy of Fallot.
Chin. Med. J.
2009;122;2
The inhibitory effect of human embryonic germ cells on ovarian cancer.
Neoplasma
2009;56;1
Pancreatic islet and stellate cells are the main sources of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 in pancreatic cancer.
Pancreatology
2009;9;1-2
Expression and prognostic significance of PDCD4 in human epithelial ovarian carcinoma.
Anticancer Res.
2008;28;5B
[ See timeline ] [ See all publications ]
means that Kong, Bo has 6 papers cited a least 6 times - methodology
Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, Jinan, China.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.